Federal Government to Test GenoMed's Approach to the Flu: Could Counter Vaccine Shortage

Article

ST. LOUIS  -- GenoMed, Inc. announced that the National Institute of Allergy and Infectious Disease (NIAID), a member institute of the National Institutes of Health, has expressed interest in testing GenoMeds approach to the flu using an animal model.

GenoMed has applied for patent protection on the use of a class of blood pressure medications in viral diseases, including the flu. This is a totally novel approach. There is no shortage of these medications worldwide.

The federal government has expressed interest in broad-spectrum viral antidotes. GenoMed met last week with federal government officials to discuss GenoMeds potential broad-spectrum viral antidote and further testing of its approach against viral diseases, including influenza. The meeting resulted in an expansion of the contract which GenoMed originally signed with NIAID in December 2003.

SOURCE: GenoMed, Inc.

Recent Videos
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Related Content